Xeltis
Developing new heart valves and coronary artery bypass grafts (cabgs) made from patients' own tissue. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$248m (Public information from Aug 2023)
Company register number 17108431
Eindhoven Noord-Brabant (HQ & founding location)
Authorizing premium user...